Roivant Sciences (ROIV) Cash & Equivalents (2021 - 2026)
Roivant Sciences (ROIV) posted Cash & Equivalents of $1.25 billion for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 0.8% from $1.24 billion a year earlier but down 12.0% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences' Cash & Equivalents came in at $1.42 billion, down 47.7% from FY2025.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -7.1% (FY2021 to FY2026).
- In prior fiscal years, Roivant Sciences' Cash & Equivalents was $2.72 billion in FY2025 (-58.2%), $6.49 billion in FY2024 (+287.3%), $1.68 billion in FY2023 (-18.6%) and $2.06 billion in FY2022 (+0.3%).
- Quarterly Cash & Equivalents has run from a low of $1.24 billion in fiscal Q2 2026 to a high of $6.7 billion in fiscal Q3 2024 over five years.
- On a year-over-year basis, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 34.6%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q3 2024, with growth of 338.6%; the weakest was fiscal Q1 2026, with a decline of 78.3%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $1.42 billion (Q4 2026), $1.48 billion (Q3 2026) and $1.24 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Roivant Sciences | 25.81 Bn | 26.50 Bn | 1.16 Mn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Bn |
| Mar 31, 2026 | 1.42 Bn |
| Dec 31, 2025 | 1.48 Bn |
| Sep 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.24 Bn |
| Mar 31, 2025 | 2.72 Bn |
| Dec 31, 2024 | 1.99 Bn |
| Sep 30, 2024 | 1.96 Bn |
| Jun 30, 2024 | 5.70 Bn |
| Mar 31, 2024 | 6.49 Bn |
| Dec 31, 2023 | 6.70 Bn |
| Sep 30, 2023 | 1.41 Bn |
| Jun 30, 2023 | 1.43 Bn |
| Mar 31, 2023 | 1.68 Bn |
| Dec 31, 2022 | 1.53 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.94 Bn |
| Mar 31, 2022 | 2.06 Bn |
| Dec 31, 2021 | 2.21 Bn |
| Sep 30, 2021 | 2.50 Bn |
API Access
Roivant Sciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();